A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.
about
The growing epidemic of hypertension among children and adolescents: a challenging road aheadFocus on prevention, diagnosis and treatment of hypertension in children and adolescentsAnti-hypertensive drugs in children and adolescentsPediatric cardiovascular drug trials, lessons learned.Short- and long-term physiologic and pharmacologic control of blood pressure in pediatric patients.Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis.Pediatric hypertension: recent trends and accomplishments, future challenges.Pediatric antihypertensive trial failures: analysis of end points and dose range.Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.Macrovascular angiopathy in children and adolescents with type 1 diabetes.Valsartan use in pediatric hypertension.Update on the pharmacologic treatment of hypertension in pediatrics.Pharmacological interventions for hypertension in children.Pharmacokinetics of olmesartan medoxomil in pediatric patients with hypertension.Pharmacologic Management of Pediatric Hypertension.Pharmacologic Treatment of Pediatric Hypertension.Therapeutic efficacy and safety of ACE inhibitors in the hypertensive paediatric population: a review.Safety of Enalapril in Infants Admitted to the Neonatal Intensive Care Unit.Synthesis and biological evaluation of decavanadate Na4Co(H2O)6V10O28.18H2O.Extrapolation of enalapril efficacy from adults to children using pharmacokinetic/pharmacodynamic modelling.Hypertension in pediatric patients with chronic kidney disease: management challenges.Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients.Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.Screening children for hypertension: the case against.Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank.
P2860
Q27009137-5DA7B5CE-6021-4DD2-BAF0-FF77115D177BQ27009545-AA9470DA-C891-484A-B8A4-872B9AB09FF1Q33772773-F81CD513-1FE3-4C20-A5C4-A0C46D78EB01Q35085596-B526A5CE-A175-4B56-8EBF-54C853309834Q35210549-57062F97-587F-4812-A355-34EED12B1BAAQ37038295-B8B573A7-DEEF-41C7-BED8-5B44D01DE777Q37147728-7CB21EDA-364D-4130-8358-3CAB85E910CAQ37436147-321E8356-CBC6-456A-9673-71C4DE558E33Q37458886-92C313B1-EB1B-4350-A9BA-63070AFBCEE7Q37857087-F9EA0CA9-6FF4-488D-A405-1A7914D06164Q37859743-45A39CB4-77AB-4A51-AA51-E9F3C4562FFFQ38016527-50D50887-D1BB-4CEE-B514-7F60447D42D7Q38252468-0D397DC5-45B3-422B-AF72-DAAFF4F6B47FQ38466210-33904811-1DDD-48EF-AD2A-7632E426AD89Q38644539-5F98150F-5D3C-4E3D-94D9-456DAE2D695CQ38799010-359493E6-368A-4FA8-920D-21ECAFE6EA07Q38967178-87B8EB32-1D91-4306-ADAA-7DE86A47A15CQ39202908-A5681A54-7236-4BF2-8E10-0276EA101092Q39996713-64D5171A-635D-4CDF-9155-8D82466A910BQ40644214-77EB102F-717A-4B77-8006-58248E9F0D5AQ41200646-47E1E0F8-E13D-4805-95C5-4F765BDE134FQ43456625-7ADF1CC9-D33C-4983-89E0-C2CCDD6D0267Q46140798-C5E9FCE9-EF84-4640-AD9A-956F60DC7FD0Q49567403-34698B1F-F28C-40A8-8497-9E660DB58B99Q50027860-817506EA-B759-445C-A1A4-C612586FDF9B
P2860
A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A double-blind, placebo-contro ...... or children with hypertension.
@ast
A double-blind, placebo-contro ...... or children with hypertension.
@en
A double-blind, placebo-contro ...... or children with hypertension.
@nl
type
label
A double-blind, placebo-contro ...... or children with hypertension.
@ast
A double-blind, placebo-contro ...... or children with hypertension.
@en
A double-blind, placebo-contro ...... or children with hypertension.
@nl
prefLabel
A double-blind, placebo-contro ...... or children with hypertension.
@ast
A double-blind, placebo-contro ...... or children with hypertension.
@en
A double-blind, placebo-contro ...... or children with hypertension.
@nl
P2093
P2860
P1476
A double-blind, placebo-contro ...... or children with hypertension.
@en
P2093
Beth Soffer
Enalapril Pediatric Hypertension Collaborative Study Group
Pamela Herrera
Shahnaz Shahinfar
Thomas Wells
Virginia Frame
Wayne Shaw
Zhongxin Zhang
P2860
P304
P356
10.1177/009127002401102786
P577
2002-08-01T00:00:00Z